Are we sure we all do the same things? Results from a GITMO survey on basic practices in allogeneic bone marrow transplantation

Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group.

The Lancet. Haematology·2026

Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.

Bone marrow transplantation·2026

Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell Transplantation.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Outcomes of CAR T-Cell Therapy in transformed indolent Non-Hodgkin Lymphomas and de novo DLBCL: A comparative analysis from the Italian CAR T-SIE study.

European journal of cancer (Oxford, England : 1990)·2026

Real-world patient-reported symptomatic adverse events and concordance with physician assessments after CAR T-cell therapy in patients with aggressive B-cell lymphomas: a prospective study.

The Lancet. Haematology·2026

Likelihood of aggressive PK/PD target attainment of continuous-infusion beta-lactams during the first week of treatment of febrile neutropenia: findings from a 1-year prospective, monocentric study in onco-haematological patients.

The Journal of antimicrobial chemotherapy·2026

Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia.

Haematologica·2026

Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial"

Haematologica·2026

Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".

Haematologica·2026

Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma.

Haematologica·2026

Belumosudil achieves clinical response in chronic graft-versus-host disease with varying organ-specific response kinetics: an analysis from the phase II ROCKstar trial.

Haematologica·2026

A pilot trial evaluating lenalidomide and oral azacitidine with radiotherapy for patients with newly diagnosed and relapsed plasmacytoma.

Haematologica·2026

Rabbit Anti-Thymocyte Globulin Versus Basiliximab in Spousal Kidney Transplant: Early Immunological and Clinical Outcomes.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026

[Serological Characteristics and Transfusion of Passenger Lymphocyte Syndrome with Multiple Antibodies after Liver Transplantation].

Zhongguo shi yan xue ye xue za zhi·2026

Incidence of Infections in Renal Allograft Recipients and Their Outcomes in a Tertiary Care Center in Northeast India.

The Journal of the Association of Physicians of India·2026

The role of macrophage polarization in organ transplantation: research progress on impact on graft injury, repair, and fibrosis.

Frontiers in immunology·2026

From First Presentation to Transplantation: Risk Factors for Severe Outcome in Pediatric Autoimmune Hepatitis.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026

Comparative Outcomes of Late Versus Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026

Related Experiment Videos

Are we sure we all do the same things? Results from a GITMO survey on basic practices in allogeneic bone marrow

Related Concept Videos

Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group.

Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.

Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell Transplantation.

Outcomes of CAR T-Cell Therapy in transformed indolent Non-Hodgkin Lymphomas and de novo DLBCL: A comparative analysis from the Italian CAR T-SIE study.

Real-world patient-reported symptomatic adverse events and concordance with physician assessments after CAR T-cell therapy in patients with aggressive B-cell lymphomas: a prospective study.

Likelihood of aggressive PK/PD target attainment of continuous-infusion beta-lactams during the first week of treatment of febrile neutropenia: findings from a 1-year prospective, monocentric study in onco-haematological patients.

Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia.

Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: "HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial"

Separating dose schedule from disease biology in CD19 CAR T-cell therapy. Comment on: "A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma".

Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma.

Belumosudil achieves clinical response in chronic graft-versus-host disease with varying organ-specific response kinetics: an analysis from the phase II ROCKstar trial.

A pilot trial evaluating lenalidomide and oral azacitidine with radiotherapy for patients with newly diagnosed and relapsed plasmacytoma.

Rabbit Anti-Thymocyte Globulin Versus Basiliximab in Spousal Kidney Transplant: Early Immunological and Clinical Outcomes.

[Serological Characteristics and Transfusion of Passenger Lymphocyte Syndrome with Multiple Antibodies after Liver Transplantation].

Incidence of Infections in Renal Allograft Recipients and Their Outcomes in a Tertiary Care Center in Northeast India.

The role of macrophage polarization in organ transplantation: research progress on impact on graft injury, repair, and fibrosis.

From First Presentation to Transplantation: Risk Factors for Severe Outcome in Pediatric Autoimmune Hepatitis.

Comparative Outcomes of Late Versus Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients.

Related Experiment Videos

Are we sure we all do the same things? Results from a GITMO survey on basic practices in allogeneic bone marrow...

Related Concept Videos

Related Articles

Are we sure we all do the same things? Results from a GITMO survey on basic practices in allogeneic bone marrow